Mannose phosphate isomerase

Mannose phosphate isomerase (MPI) is an enzyme that plays a crucial role in the metabolism of mannose, a type of sugar that is important for human health. This enzyme catalyzes the interconversion of mannose-6-phosphate and fructose-6-phosphate, a key step in the mannose salvage pathway. This pathway is essential for the proper utilization of mannose within the cell and is critical for various cellular functions, including glycosylation processes, which are important for protein folding and stability.

Function

Mannose phosphate isomerase functions by catalyzing the isomerization of mannose-6-phosphate to fructose-6-phosphate. This reaction is reversible and plays a significant role in the mannose salvage pathway, allowing cells to efficiently use mannose obtained either from the diet or from the degradation of glycoproteins. Fructose-6-phosphate produced by MPI can enter the glycolysis pathway, a central metabolic pathway that generates energy for the cell.

Clinical Significance

Mutations in the gene encoding mannose phosphate isomerase (MPI) can lead to a rare but serious condition known as Congenital Disorders of Glycosylation (CDG), specifically type Ib (CDG-Ib). Patients with CDG-Ib exhibit a variety of symptoms, including protein-losing enteropathy, hypoglycemia, and failure to thrive. Early diagnosis and treatment, often involving dietary mannose supplementation, are crucial for managing this condition.

Genetic

The MPI gene is located on human chromosome 15 and contains the instructions for producing the mannose phosphate isomerase enzyme. Variants in the MPI gene can affect the enzyme's function, leading to metabolic disorders such as CDG-Ib. Genetic testing can identify mutations in the MPI gene, which is essential for diagnosing the condition and guiding treatment strategies.

Biochemical Pathways

Mannose phosphate isomerase is involved in the mannose salvage pathway, which is part of a larger network of metabolic pathways that include glycolysis and gluconeogenesis. The enzyme's role in converting mannose-6-phosphate to fructose-6-phosphate links the metabolism of mannose directly to these central metabolic pathways, highlighting the importance of MPI in energy production and cellular metabolism.

Treatment and Management

For individuals with CDG-Ib caused by MPI deficiency, mannose supplementation can be an effective treatment. Mannose is administered orally and can help bypass the metabolic block caused by the enzyme deficiency, improving symptoms and quality of life for affected individuals. Management of CDG-Ib also involves supportive care and monitoring for potential complications.

Research Directions

Ongoing research aims to better understand the molecular mechanisms underlying MPI function and its role in human health and disease. Studies on the structure and function of the enzyme, as well as the development of novel therapeutic approaches for treating MPI-related disorders, are areas of active investigation.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian